InvestorsHub Logo
Followers 1
Posts 77
Boards Moderated 0
Alias Born 12/08/2011

Re: None

Wednesday, 12/31/2014 10:49:33 AM

Wednesday, December 31, 2014 10:49:33 AM

Post# of 346056
Change on www.clinicaltrials.gov/ct2/show/NCT01323062?term=bavituximab&rank=12

NCT01323062
Bavituximab Plus Carbo and Pemetrexed in Chemo-Naive Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Subjects

This study is ongoing, but not recruiting participants.

Have we gotten a fully enrolled PR?
What do we know?

I know it's an IST we don't have to know anything.
MG
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News